A study of Supraflex Cruz stents for multivessel heart disease
Part of Heart & circulation clinical trials.
This trial is monitoring patients who receive Supraflex Cruz stents in multiple blocked heart arteries. It aims to gather real-world safety and effectiveness data to help improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have blockages in more than one heart artery that cause symptoms (like chest pain or shortness of breath).
- You are willing to get at least two Supraflex Cruz stents placed during your procedure.
- You understand the registry and give permission to collect your medical information.
- You are not pregnant or breastfeeding.
- You do not have allergies to common blood thinners or the stent materials.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how safe and effective a specific stent (SUPRAFLEX CRUZ) is when used in real-world care for people with heart artery blockages in more than one artery. Some participants will also be selected if their heart pumping strength is reduced.
This study is a follow-up registry that tracks how people do after doctors place a specific type of drug-eluting coronary stent. It may help doctors understand safety and outcomes of the Supraflex stent in real-world care.
This trial tests a new type of heart stent in people who also take daily blood thinners. The stent is very thin and releases medicine over time to help keep the artery open, and the coating eventually dissolves. It may be a safer option for people on blood thinners who need a stent.
This trial tests a new stent (a small mesh tube) to open narrowed heart arteries and improve blood flow. It may help people with multiple blocked arteries who are having a procedure to widen them.
This study looks at how well doctors can treat multiple blocked heart arteries using a specific drug-eluting stent, aiming to fully open them. It may help patients whose blockage pattern fits the study, but it does not include certain high-risk or special cases.
This trial tests a new drug-coated stent (GENOSS® DES) for people with blockages in multiple heart arteries. It aims to see how safe and effective the stent is for these patients.
Hear when a new Patient Population With Multivessel Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.